ALS Centre – Neurology Departement – CHU Dupuytren

CHU Dupuytren

Care missions: – Provide diagnosis of motoneuron diseases – Conduct multidisciplinary evaluation every 3 months Provide medical and social support – Organize home support

Limoges_logo
  • Training missions: – Organize training actions for the medical and paramedical staff – Share specific knowledges on ALS patient’s care – Participate in and get involved in working groups during the coordination symposium of French ALS centres.
  • Research missions: – Ensure clinical research activities through the establishment of internal and multicenter research protocols: area of research: epidemiology, cognition and nutrition – Participate in therapeutic research in collaboration with the pharmaceutical industry – Communicate the results of research through oral or displayed communications – Publish the results of research into national and international levels

 

Contact
Location
2 Avenue Martin Luther King, Limoges, France

Specialists

Current trials
Recruiting
Phase iii

TUDCA-ALS (TUDCA)

Industry sponsored trial

TUDCA (tauroursodeoxycholic acid) is a small molecule that is being explored for its potential as a treatment for ALS

Read more
In preparation
Phase iii

PreLude (Lithium carbonate)

Platform trial arm

Within an innovative platform design study, we will evaluate the efficacy of lithium carbonate in UNC13a homozygous patients.

Read more
In preparation
Phase ii

Lighthouse (Triumeq)

Platform trial arm

Within an innovative platform design study, we will evaluate the efficacy of Triumeq, a therapy developed for treatment of HIV that has shown to slow progression in ALS

Read more
In preparation
Phase iii

iAdore (Oral edaravone)

Platform trial arm

Within an innovative platform design study, we will evaluate the efficacy of oral edaravone (TW001), a formulation that reduces oxidative stress

Read more